5 insiders reported 28 Form 4 transactions for VYNE Therapeutics Inc. (VYNE) over the past 18 months (most recent 2026-07-02). Recent activity: Harsch Mutya (CHIEF LEGAL OFFICER AND GC) Sell 3,464 shares, Domzalski David (PRESIDENT AND CEO) Sell 12,214 shares, Stuart Iain (CHIEF SCIENTIFIC OFFICER) Sell 2,370 shares, Zeronda Tyler (CHIEF FINANCIAL OFFICER) Sell 3,464 shares, Domzalski David (PRESIDENT AND CEO) Buy 30,791 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | Harsch Mutya | CHIEF LEGAL OFFICER AND GC | Sell | 3,464 | $2,254 |
| 2026-07-02 | Domzalski David | PRESIDENT AND CEO | Sell | 12,214 | $7,948 |
| 2026-07-02 | Stuart Iain | CHIEF SCIENTIFIC OFFICER | Sell | 2,370 | $1,542 |
| 2026-07-02 | Zeronda Tyler | CHIEF FINANCIAL OFFICER | Sell | 3,464 | $2,254 |
| 2026-06-02 | Domzalski David | PRESIDENT AND CEO | Buy | 30,791 | $9,545 |
| 2026-04-02 | Stuart Iain | CHIEF SCIENTIFIC OFFICER | Sell | 2,876 | $1,718 |
| 2026-04-02 | Domzalski David | PRESIDENT AND CEO | Sell | 14,232 | $8,504 |
| 2026-04-02 | Harsch Mutya | CHIEF LEGAL OFFICER AND GC | Sell | 4,007 | $2,394 |
| 2026-04-02 | Zeronda Tyler | CHIEF FINANCIAL OFFICER | Sell | 4,007 | $2,394 |
| 2026-01-05 | Zeronda Tyler | CHIEF FINANCIAL OFFICER | Sell | 7,858 | $4,558 |
| 2026-01-05 | Stuart Iain | CHIEF SCIENTIFIC OFFICER | Sell | 2,448 | $1,420 |
| 2026-01-05 | Harsch Mutya | CHIEF LEGAL OFFICER AND GC | Sell | 3,579 | $2,076 |
| 2026-01-05 | Domzalski David | PRESIDENT AND CEO | Sell | 12,684 | $7,357 |
| 2025-10-02 | Stuart Iain | CHIEF SCIENTIFIC OFFICER | Sell | 2,453 | $834 |
| 2025-10-02 | Domzalski David | PRESIDENT AND CEO | Sell | 12,676 | $4,310 |
| 2025-10-02 | Harsch Mutya | CHIEF LEGAL OFFICER AND GC | Sell | 3,581 | $1,218 |
| 2025-10-02 | Zeronda Tyler | CHIEF FINANCIAL OFFICER | Sell | 3,420 | $1,163 |
| 2025-07-02 | Harsch Mutya | CHIEF LEGAL OFFICER AND GC | Sell | 3,581 | $5,909 |
| 2025-07-02 | Stuart Iain | CHIEF SCIENTIFIC OFFICER | Sell | 2,453 | $4,047 |
| 2025-07-02 | Domzalski David | PRESIDENT AND CEO | Sell | 12,676 | $20,915 |
| 2025-07-02 | Zeronda Tyler | CHIEF FINANCIAL OFFICER | Sell | 3,420 | $5,643 |
| 2025-06-03 | Domzalski David | PRESIDENT AND CEO | Buy | 8,681 | $7,032 |
| 2025-06-03 | Harsch Mutya | CHIEF LEGAL OFFICER AND GC | Buy | 1,145 | $927 |
| 2025-04-02 | Domzalski David | PRESIDENT AND CEO | Sell | 30,498 | $48,187 |
| 2025-04-02 | Stuart Iain | CHIEF SCIENTIFIC OFFICER | Sell | 6,044 | $9,550 |
Source: SEC Form 4 filings · as of 2026-07-02